Kynurenic acid attenuates MPP+-induced dopaminergic neuronal cell death via a Bax-mediated mitochondrial pathway

European Journal of Cell Biology - Tập 87 Số 6 - Trang 389-397 - 2008
Doyeon Lee1,2, Kyu-Sun Lee3, Hyun Jung Lee1, Young Noh1, Do Hee Kim1, Jun‐Young Lee4, Sang Won Seo5, Ok Ja Yoon6, Won Bok Lee1, Kyung Yong Kim1, Yoon Hee Chung1, Sung Soo Kim1
1Department of Anatomy and Cell Biology, College of Medicine, Chung-Ang University, 221 Huksuk-dong, Dongjak-ku, Seoul 156-756, Republic of Korea
2Department of Herbal Resources Research, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea
3Center for Regenerative Medicine, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea
4Department of Neuropsychiatry, College of Medicine, Seoul National University, Seoul, Republic of Korea
5Department of Family Medicine, College of Medicine, Chung-Ang University, Seoul, Republic of Korea
6School of Advanced Materials Science and Engineering and Center for Advanced Plasma Surface Technology, Sungkyunkwan University, Suwon, Republic of Korea

Tóm tắt

Từ khóa


Tài liệu tham khảo

Antonsson, 1997, Inhibition of Bax channel-forming activity by Bcl-2, Science, 277, 370, 10.1126/science.277.5324.370

Beal, 1992, Kynurenic acid concentrations are reduced in Huntington's disease cerebral cortex, J. Neurol. Sci., 108, 80, 10.1016/0022-510X(92)90191-M

Bhagwat, 1995, Brain mitochondrial cytochromes P450: xenobiotic metabolism, presence of multiple forms and their selective inducibility, Arch. Biochem. Biophys., 320, 73, 10.1006/abbi.1995.1344

Biedler, 1978, Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones, Cancer Res., 38, 3751

Chetsawang, 2007, Melatonin inhibits MPP+-induced caspase-mediated death pathway and DNA fragmentation factor-45 cleavage in SK-N-SH cultured cells, J. Pineal Res., 43, 115, 10.1111/j.1600-079X.2007.00449.x

Cozzi, 1999, Kynurenine hydroxylase inhibitors reduce ischemic brain damage: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2yl]-benzenesulfonamide (Ro 61-8048) in models of focal or global brain ischemia, J. Cereb. Blood Flow Metab., 19, 771, 10.1097/00004647-199907000-00007

Dennis, 2003, Interactions among nitric oxide and Bcl-family proteins after MPP+ exposure of SH-SY5Y neural cells I: MPP+ increases mitochondrial NO and Bax protein, J. Neurosci. Res., 72, 76, 10.1002/jnr.10539

Eberhardt, 2003, Apoptotic mechanisms and antiapoptotic therapy in the MPTP model of Parkinson's disease, Toxicol. Lett., 139, 135, 10.1016/S0378-4274(02)00428-9

Fan, 2006, Heat shock proteins reduce alpha-synuclein aggregation induced by MPP+ in SK-N-SH cells, FEBS Lett., 580, 3091, 10.1016/j.febslet.2006.04.057

Fukui, 1991, Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism, J. Neurochem., 56, 2007, 10.1111/j.1471-4159.1991.tb03460.x

Gonzalez-Polo, 2003, Vitamin E blocks early events induced by 1-methyl-4-phenylpyridinium (MPP+) in cerebellar granule cells, J. Neurochem., 84, 305, 10.1046/j.1471-4159.2003.01520.x

Green, 1998, Mitochondria and apoptosis, Science, 281, 1309, 10.1126/science.281.5381.1309

Gross, 1998, Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis, EMBO J., 17, 3878, 10.1093/emboj/17.14.3878

Hartmann, 2001, Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?, J. Neurochem., 76, 1785, 10.1046/j.1471-4159.2001.00160.x

Jacquy, 1993, Long-latency auditory evoked responses in Parkinson disease and in parkinsonism induced by neuroleptics, Acta Neurol. Belg., 93, 119

Jung, 2007, Rosiglitazone protects human neuroblastoma SH-SY5Y cells against MPP+ induced cytotoxicity via inhibition of mitochondrial dysfunction and ROS production, J. Neurol. Sci., 253, 53, 10.1016/j.jns.2006.11.020

Kotake, 2003, MPP+ analogs acting on mitochondria and inducing neuro-degeneration, Curr. Med. Chem., 10, 2507, 10.2174/0929867033456558

Kroemer, 2000, Mitochondrial control of cell death, Nat. Med., 6, 513, 10.1038/74994

Lee do, 2006, ERK1/2 activation attenuates TRAIL-induced apoptosis through the regulation of mitochondria-dependent pathway, Toxicol. In Vitro, 20, 816, 10.1016/j.tiv.2006.01.007

Leeson, 1991, Kynurenic acid derivatives. Structure-activity relationships for excitatory amino acid antagonism and identification of potent and selective antagonists at the glycine site on the N-methyl-d-aspartate receptor, J. Med. Chem., 34, 1243, 10.1021/jm00108a002

Lu, 2006, Leptin inhibits 1-methyl-4-phenylpyridinium-induced cell death in SH-SY5Y cells, Neurosci. Lett., 407, 240, 10.1016/j.neulet.2006.08.053

Luchowska, 2003, FK506 attenuates 1-methyl-4-phenylpyridinium- and 3-nitropropionic acid-evoked inhibition of kynurenic acid synthesis in rat cortical slices, Acta Neurobiol. Exp. (Warsaw), 63, 101, 10.55782/ane-2003-1459

Luchowski, 2002, 1-Methyl-4-phenylpyridinium and 3-nitropropionic acid diminish cortical synthesis of kynurenic acid via interference with kynurenine aminotransferases in rats, Neurosci. Lett., 330, 49, 10.1016/S0304-3940(02)00735-8

Maciel, 2004, Mitochondrial permeability transition in neuronal damage promoted by Ca2+ and respiratory chain complex II inhibition, J. Neurochem., 90, 1025, 10.1111/j.1471-4159.2004.02565.x

Markey, 1984, Intraneuronal generation of a pyridinium metabolite may cause drug-induced Parkinsonism, Nature, 311, 464, 10.1038/311464a0

Melov, 2000, Mitochondrial oxidative stress. Physiologic consequences and potential for a role in aging, Ann. NY Acad. Sci., 908, 219, 10.1111/j.1749-6632.2000.tb06649.x

Nicotra, 2002, Apoptotic molecules and MPTP-induced cell death, Neurotoxicol. Teratol., 24, 599, 10.1016/S0892-0362(02)00213-1

Ogawa, 1992, Kynurenine pathway abnormalities in Parkinson's disease, Neurology, 42, 1702, 10.1212/WNL.42.9.1702

Ramsay, 1991, Interaction of 1-methyl-4-phenylpyridinium ion (MPP+) and its analogs with the rotenone/piericidin binding site of NADH dehydrogenase, J. Neurochem., 56, 1184, 10.1111/j.1471-4159.1991.tb11409.x

Scharfman, 1997, Pretreatment with l–kynurenine, the precursor to the excitatory amino acid antagonist kynurenic acid, suppresses epileptiform activity in combined entorhinal/hippocampal slices, Neurosci. Lett., 224, 115, 10.1016/S0304-3940(97)13472-3

Schwieler, 2006, Effects of COX-1 and COX-2 inhibitors on the firing of rat midbrain dopaminergic neurons – possible involvement of endogenous kynurenic acid, Synapse, 59, 290, 10.1002/syn.20241

Stone, 2000, Development and therapeutic potential of kynurenic acid and kynurenine derivatives for neuroprotection, Trends Pharmacol. Sci., 21, 149, 10.1016/S0165-6147(00)01451-6

Stone, 2001, Endogenous neurotoxins from tryptophan, Toxicon, 39, 61, 10.1016/S0041-0101(00)00156-2

Szerb, 1992, Effect of ammonium ions on synaptic transmission in the mammalian central nervous system, Prog. Neurobiol., 39, 135, 10.1016/0301-0082(92)90008-3

Wang, 2001, The expanding role of mitochondria in apoptosis, Genes Dev., 15, 2922

Wolf, 1971, Studies on tryptophan metabolism in male subjects treated with hydrocortisone, J. Clin. Endocrinol. Metab., 33, 838, 10.1210/jcem-33-5-838

Yamamoto, 1995, Studies on cerebrospinal fluid kynurenic acid concentrations in epileptic children, Brain Dev., 17, 327, 10.1016/0387-7604(95)00065-J